TABLE 1 Hematological Characteristics of the 70 Patients with Ph1+-CML Under Study

From: Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential Trephine Biopsies of the Bone Marrow

Parameter

Mean ± SD

Leukocytes (× 109/L)

112 ± 104

 Polymorphonuclear

46.1 ± 16.4

 Granulocytes

 

 Myeloblasts (%)

2.4 ± 3.7

 Promyelocytes (%)

2.8 ± 2.9

 Myelocytes (%)

12.1 ± 7.3

 Normo-erythroblasts (%)

1.0 ± 2.3

Eosinophils (%)

2.7 ± 3.2

Basophils (%)

4.3 ± 4.0

Lymphocytes (%)

9.6 ± 8.4

Erythrocytes (× 1012/L)

4.0 ± 0.6

Hemoglobin (g/dL)

12.8 ± 1.8

Platelets (× 109/L)

539 ± 436

LDH (U/L)

622 ± 316

ALP (score)a

13 ± 25

Spleen sizeb

2.1 ± 2.9

Liver sizeb

0.4 ± 0.8

  1. aa ALP-alkaline leukocyte phosphatase - normal score 20–80
  2. bb Spleen-Liver size - cm below costal margin.
Back to article page